Literature DB >> 33877590

Evaluation of iron, ferritin, copper, and ceruloplasmin along with proviral load in human T lymphotropic virus type 1-associated myelopathy.

Reza Boostani1, Mina Khodabandeh2, Seyyed Abdolrahim Rezaee2, Houshang Rafatpanah2, Sanaz Ahmadi Ghezeldasht3, Zohreh Vahidi2, Zahra Baghestani4.   

Abstract

Human T-cell lymphotropic virus type 1 (HTLV-1) infection can cause HTLV-I-associated myelopathy (HAM). In this study, we evaluated the levels of serum iron, ferritin, copper, and ceruloplasmin, and their correlations with HTLV-1 proviral load (PVL) and standard indices of HAM severity. In total, 114 subjects were recruited in this cross sectional study in Qaem Hospital, Mashhad, Iran between 2017 and 2018, including 36 HAM and 32 asymptomatic cases (ACs) and 46 healthy people (HSs). The clinical examination and evaluation of serum levels of biochemical factors and proviral load were performed. The PVL in HAM and ACs were 1835.49 ± 382.81 and 280.97 ± 67.41 copies/104 PBMCs, which statistically differed. Significant differences were also observed in plasma levels of iron, copper, and ceruloplasmin, among the three groups, while ferritin level was not considerably different. For HAM severity, the mean Osame motor disability scale (OMDS) and overactive bladder-validated-8-questionnaire (OABV-8) scores were 4.97 ± 0.38 and 15.75 ± 0.83, respectively, that had no significant correlations with the biochemical variables. Even though the studied elements in HAM group did not affect the severity of the disease, the levels of copper and ceruloplasmin might be determinants of the development and progression of HAM, as they are shown to play role in progression of other neurological diseases.
© 2021. Journal of NeuroVirology, Inc.

Entities:  

Keywords:  Copper; Ferritins; HAM/TSP; HTLV-1; Iron

Mesh:

Substances:

Year:  2021        PMID: 33877590     DOI: 10.1007/s13365-021-00961-5

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  13 in total

1.  Human T lymphotropic virus type I (HTLV-I) proviral load in cerebrospinal fluid: a new criterion for the diagnosis of HTLV-I-associated myelopathy/tropical spastic paraparesis?

Authors:  Agnes Lezin; Stephane Olindo; Stephanie Oliere; Michel Varrin-Doyer; Regine Marlin; Philippe Cabre; Didier Smadja; Raymond Cesaire
Journal:  J Infect Dis       Date:  2005-04-28       Impact factor: 5.226

Review 2.  Cellular immune response to HTLV-1.

Authors:  Charles R M Bangham; Mitsuhiro Osame
Journal:  Oncogene       Date:  2005-09-05       Impact factor: 9.867

Review 3.  The neurology of HTLV-1 infection.

Authors:  Sarah A Cooper; Maarten Schim van der Loeff; Graham P Taylor
Journal:  Pract Neurol       Date:  2009-02

4.  Human leukocyte antigen concordance and the transmission risk via breast-feeding of human T cell lymphotropic virus type I.

Authors:  Robert J Biggar; Jennifer Ng; Norma Kim; Michie Hisada; Hong-Chuan Li; Beverley Cranston; Barrie Hanchard; Elizabeth M Maloney
Journal:  J Infect Dis       Date:  2005-12-14       Impact factor: 5.226

5.  Evaluation of T Regulatory Lymphocytes Transcription Factors in HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) Patients.

Authors:  Sanaz Ahmadi Ghezeldasht; Hamed Sadeghian; Mahmoud Reza Azarpazhooh; Seyyed Ali Akbar Shamsian; Houshang Rafatpanah; Mahmood Mahmoodi; Seyyed Abdolrahim Rezaee
Journal:  Appl Biochem Biotechnol       Date:  2017-01-18       Impact factor: 2.926

6.  High prevalence of HTLV-I infection in Mashhad, Northeast Iran: a population-based seroepidemiology survey.

Authors:  Houshang Rafatpanah; Mohammad Reza Hedayati-Moghaddam; Farhad Fathimoghadam; Hamid Reza Bidkhori; Seyed Khosro Shamsian; Sanaz Ahmadi; Leila Sohgandi; Mahmoud Reza Azarpazhooh; Seyed Abdolrahim Rezaee; Reza Farid; Ali Bazarbachi
Journal:  J Clin Virol       Date:  2011-08-15       Impact factor: 3.168

7.  Brain magnetic resonance imaging white matter lesions are frequent in HTLV-I carriers and do not discriminate from HAM/TSP.

Authors:  Daniel J Morgan; Marina F Caskey; Cristiane Abbehusen; Jamary Oliveira-Filho; Cesar Araujo; Aurelia F Porto; Silvane Braga Santos; Gloria O Orge; Maria Jose Joia; Andre L Muniz; Isadora Siqueira; Marshall J Glesby; Edgar Carvalho
Journal:  AIDS Res Hum Retroviruses       Date:  2007-12       Impact factor: 2.205

Review 8.  Viral infection and iron metabolism.

Authors:  Hal Drakesmith; Andrew Prentice
Journal:  Nat Rev Microbiol       Date:  2008-07       Impact factor: 60.633

9.  Khorasan Disease: Prevalence of HTLV-I Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) In West Azarbaijan from 2004 to 2007.

Authors:  R Boostani; A Mellat Ardakani; H Ashrafi
Journal:  Iran Red Crescent Med J       Date:  2011-06-01       Impact factor: 0.611

10.  Population-based Seroprevalence of HTLV-I Infection in Golestan Province, South East of Caspian Sea, Iran.

Authors:  Khodaberdi Kalavi; Abdolvahab Moradi; Alijan Tabarraei
Journal:  Iran J Basic Med Sci       Date:  2013-03       Impact factor: 2.699

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.